VivoSim Labs, Inc. Current Liabilities
VivoSim Labs, Inc. (VIVS) had Current Liabilities of $1.89 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-12
- 2026-06-30: Liabilities, Current $1.89M.
- 2026-03-31: Liabilities, Current $2.79M.
- 2025-12-31: Liabilities, Current $2.48M.
- 2025-09-30: Liabilities, Current $2.45M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.89M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $2.79M 10-Q · filed 2026-08-12 | |
| 2025-12-31 | $2.48M 10-Q · filed 2026-02-11 | |
| 2025-09-30 | $2.45M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $2.14M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $3.74M 10-K · filed 2026-07-14 | |
| 2024-12-31 | $2.94M 10-Q · filed 2025-02-19 | |
| 2024-09-30 | $2.41M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $2.03M 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $1.86M 10-K · filed 2025-06-05 | |
| 2023-12-31 | $1.70M 10-Q · filed 2024-02-08 | |
| 2023-09-30 | $1.60M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $1.77M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $3.67M 10-K · filed 2024-05-31 | |
| 2022-12-31 | $1.38M 10-Q · filed 2023-02-09 | |
| 2022-09-30 | $1.39M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $1.28M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $1.38M 10-K · filed 2023-07-14 | |
| 2021-12-31 | $2.01M 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $1.68M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $964.00K 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $721.00K 10-K · filed 2022-06-10 | |
| 2020-12-31 | $829.00K 10-Q · filed 2021-02-08 | |
| 2020-09-30 | $658.00K 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $835.00K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $1.81M 10-K · filed 2021-06-15 | |
| 2019-12-31 | $2.36M 10-Q · filed 2020-02-10 | |
| 2019-09-30 | $3.12M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $3.54M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $3.74M 10-K · filed 2020-05-28 | |
| 2018-12-31 | $3.41M 10-Q · filed 2019-02-07 | |
| 2018-09-30 | $3.29M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $3.21M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $4.66M 10-K · filed 2019-06-03 | |
| 2017-12-31 | $4.30M 10-Q · filed 2018-02-08 | |
| 2017-09-30 | $4.13M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $3.69M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $6.01M 10-K · filed 2018-05-31 | |
| 2016-12-31 | $4.44M 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $4.22M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $3.14M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $4.49M 10-K · filed 2017-06-07 | |
| 2015-12-31 | $5.50M 10-Q · filed 2016-02-08 | |
| 2015-09-30 | $5.52M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $5.22M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $4.76M 10-K · filed 2016-06-09 | |
| 2014-12-31 | $3.72M 10-Q · filed 2015-02-06 | |
| 2014-09-30 | $3.11M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $3.08M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $1.89M 10-K · filed 2015-06-09 | |
| 2013-12-31 | $2.90M 10-Q · filed 2014-02-06 | |
| 2013-09-30 | $2.94M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $7.58M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $8.38M 10-K · filed 2014-06-10 | |
| 2012-12-31 | $22.04M 10-K · filed 2014-06-10 | |
| 2012-09-30 | $976.23K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $889.01K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $1.11M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $1.98M 10-KT · filed 2013-05-24 | $1.98M 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |